Advertisement

Did Goethe Describe Attention Deficit Hyperactivity Disorder?

03:25 EDT 23rd May 2013 | BioPortfolio

Summary of "Did Goethe Describe Attention Deficit Hyperactivity Disorder?"

As early as 1846, the typical symptoms of attention deficit hyperactivity disorder (ADHD) were described by Heinrich Hoffmann (1809-1894). However, in Goethe's masterpiece Faust (1832), the character of Euphorion strongly suggests ADHD diagnosis.

Affiliation

Department of Neurological Sciences, Bologna University, Bologna, Italy.

Journal Details

This article was published in the following journal.

Name: European neurology
ISSN: 1421-9913
Pages: 70-71

Links

Medical and Biotech [MESH] Definitions

Attention Deficit Disorder With Hyperactivity

A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-IV)

Dextroamphetamine

The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.

Methylphenidate

A central nervous system stimulant used most commonly in the treatment of attention-deficit disorders in children and for narcolepsy. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE.

Imipramine

The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.

PubMed Articles [ 8730 Associated PubMed Articles listed on BioPortfolio]

Cardiovascular considerations of attention deficit hyperactivity disorder medications: a report of the European Network on Hyperactivity Disorders work group, European Attention Deficit Hyperactivity Disorder Guidelines Group on attention deficit hyperact

Memory-guided saccades in youth-onset psychosis and attention deficit hyperactivity disorder (ADHD).

AIM: Working memory deficits have been shown to be present in children and adolescents with schizophrenia and attention deficit hyperactivity disorder. Considering the differences in clinical characte...

Diagnosis of Attention Deficit Hyperactivity Disorder Using a Conditioned Reflex Approach.

A conditioned reflex method was developed for the diagnosis of attention deficit hyperactivity disorder using an automated apparatus containing a radial maze with a hidden search object (reward), wher...

Teachers and attention deficit and/or hyperactivity disorder: a pilot study on the situation of teachers in Tyrol.

BACKGROUND: Given the high prevalence of approximately 5 % of Attention Deficit and/or Hyperactivity Disorder in children the level of knowledge of Tyrolean educators at selected educational institu...

Acupuncture for treating attention deficit hyperactivity disorder: A systematic review and meta-analysis.

To assess the effectiveness of acupuncture as a treatment option for attention deficit hyperactivity disorder (ADHD).

Clinical Trials [ 2545 Associated Clinical Trials listed on BioPortfolio]

Atomoxetine for Attention Deficit Hyperactivity Disorder in Adolescents With Substance Use Disorder

The purpose of this study is to find out whether atomoxetine (also called Strattera) helps teenagers (12-19) with Attention Deficit Hyperactivity Disorder (ADHD) and drug/alcohol problems.

A Study for Patients With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine

The purpose of the study is to investigate the relationship of changes in measures of academic performance and problem behaviors, to changes in core Attention-Deficit/Hyperactivity Disorde...

Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

The purpose of this study is to test if the investigational medication ABT-089 is a safe and effective treatment for children with Attention Deficit Hyperactivity Disorder (ADHD).

Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study)

This study will determine the advantages and disadvantages of adding one of two different types of drugs to stimulant treatment for reducing aggressive behavior in children with attention...

Study of Aripiprazole (Abilify) in Children With ADHD (Attention Deficit Hyperactivity Disorder)

To look at the cognitive effects of abilify in children with a primary diagnosis of Attention Deficit Hyperactivity Disorder. To examine the safety, effectiveness and tolerability of abili...

Search BioPortfolio: